Friday, March 4, 2016

Fair Game: A Troubling Timeline at Valeant

A growing trickle of head-scratching news adds to gaps in Valeant Pharmaceuticals’ financial disclosures, despite attempts to burnish results.









Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)